1965 BLUMBERG, Baruch Samuel (1925 – 2011); ALTER, Harvey James (1935 – ); VISNICH, S.; ET AL
A “new” antigen in leukemia sera.
(Order of authorship in the original publication: Blumberg, Alter, Visnich.) Discovery of Australia antigen, hepatitis B antigen, Aa, later called HBsAg. Blumberg received half of the Nobel Prize for Medicine in Biolo…
GMN 3666.4 · https://historyofmedicine.com/id/4823
1968 BLUMBERG, Baruch Samuel (1925 – 2011); BAYER, Manfred E. (1928 – 2015); WERNER, Barbara G.
Particles associated with Australia antigen in the sera of patients with leukemia, Down's syndrome and hepatitis.
Particles with the appearance of a virus were detected by electron microscopy in the serum of individuals with Au. These were subsequently shown to be the surface antigen particles, different from the whole virus part…
GMN 6840 · https://historyofmedicine.com/id/9004
1969 –1972 BLUMBERG, Baruch Samuel (1925 – 2011); MILLMAN, Irving (1923 – 2012)
Vaccine against viral hepatitis and process. Serial No. 864,788 filed 10 /8 /[19]69. Patent 3636191 issued 1/ 18/ [19]72.
First description of the hepatitis B vaccine, the first cancer vaccine, US patent 3636191A. Millman and Blumberg discovered that the blood of individuals carrying the hepatitis B virus contained particles of the outsi…
GMN 6841 · https://historyofmedicine.com/id/9005
1970 DANE, David Maurice Surrey (1923 – 1998); CAMERON, C. H.; BRIGGS, E. Moya
Virus-like particles in serum of patients with Australia-antigen-associated hepatitis.
(Order of authorship in the original publication: Dane, Cameron, Briggs.) The authors showed that the "Australian antigen" was a virus causing hepatitis B. (Thanks to Juan Weiss for this reference and its interpretati…
GMN 12305 · https://historyofmedicine.com/id/14527
1970 SHERLOCK, Sheila Patricia Violet Dame (1918 – 2001); NIAZI, S. P.; FOX, R. A.
Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum.
(Order of authorship in the original publication: Sherlock, Niazi, Fox...). The authors demonstrated that the hepatitis B virus can cause cancer. (Thanks to Juan Weiss for this reference and its interpretation.)
GMN 12306 · https://historyofmedicine.com/id/14528
1970 BLUMBERG, Baruch Samuel (1925 – 2011); MILLMAN, Irving (1923 – 2012); BAYER, Manfred E. (1928 – 2015); LOEB, Lawrence A.
Australia antigen (a hepatitis-associated antigen). Purification and physical properties.
Purification of the Australia antigen and investigation of its physical properties. (Order of authorship in the original publication: Millman, Loeb, Bayer, Blumberg.) Blumberg shared the 1976 Nobel Prize in Physiology…
GMN 12321 · https://historyofmedicine.com/id/14544
1973 FEINSTONE, Stephen Mark; KAPIKIAN, Albert Zaven (1930 – 2014); PURCELL, Robert Harry (1935 – )
Hepatitis A: Detection by immune electron microscopy of a viruslike antigen associated with acute illness.
Identification of the Hepatitis A virus.
GMN 12652 · https://historyofmedicine.com/id/14895
1978 ALTER, Harvey James (1935 – ); PURCELL, Robert Harry (1935 – ); HOLLAND, Paul; ET AL
Transmissible agent in non-A, non-B hepatitis.
The first paper recording the discovery of what was, eleven years later in 1989, named the hepatitis C virus (see No. 12653). Harvey Alter and colleagues inoculated the serum/plasma of 4 patients with non-A/non-B hepa…
GMN 13540 · https://historyofmedicine.com/id/15817
1989 HOUGHTON, Michael; CHOO, Qui-Lim; KUO, George Ching-Hung; BRADLEY, Daniel W. (1941 – ); OVERBY, Lacy Rasco (1920 – 1994); WEINER, A. J.
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.
In this paper Houghton and colleagues named “hepatitis C” for the first time. They cloned and isolated the viral RNA genome and demonstrated that a patient who had high antibodies to a ‘native/wild strain’, reacted sp…
GMN 12653 · https://historyofmedicine.com/id/14896
1997 RICE, Charles Moen (1952 – ); KOLYKHALOV, Alexander M; AGAPOV, Eugene V.; ET AL
Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA.
Rice and colleagues constructed a viral RNA genome with the 3’ region and a consensus region to exclude potential inactivating mutations, which was then injected into the liver of chimps. That RNA, specifically encode…
GMN 13541 · https://historyofmedicine.com/id/15818
